Search Results 51-60 of 17187 for ulcerative colitis

  1. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...

  2. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  3. The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease - Mayo Clinic

    While small bowel CE has been fairly well studied in CD , colon capsule endoscopy (CCE) for ulcerative colitis (UC) has not been as well studied. Therefore ...

  4. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  5. Pseudomembranous colitis - Symptoms & causes - Mayo Clinic

    Certain diseases that affect the colon, such as ulcerative colitis or Crohn's disease, also may put people at risk of pseudomembranous colitis. C. difficile ...

  6. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  7. Mayo Clinic Q&A podcast: The increasing prevalence of inflammatory bowel disease

    William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, ...

  8. Balsalazide (oral route) - Mayo Clinic

    Balsalazide capsules are used to treat mild to moderately active ulcerative colitis in patients 5 years of age and older. Balsalazide tablets are used to ...

  9. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...

  10. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

    ... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.